Clinical Trial Update: Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects [Phase 1, Phase 2]

View source ↗

Summary

Alzamend Neuro completed a multiple ascending dose study evaluating safety, tolerability, and pharmacokinetics of AL001 in Alzheimer's disease patients and heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AL001

Snippet

Sponsor: Alzamend Neuro, Inc. | Conditions: Alzheimer's Disease, Healthy Non-elderly and Elderly Adults | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-14